News summary

Five-year data of continuous Leqembi® treatment show increasing benefit over time

Source: PR Newswire • Published: 17 Nov 2026, 03:19

Summarized by Masters of Longevity from PR Newswire.

Five-year data showed greater clinical benefit with continuous Leqembi in early Alzheimer's disease.

Five-year data of continuous Leqembi® treatment show increasing benefit over time
Key Takeaways
  • Five years of Leqembi showed increasing cognitive benefit.
  • Sixty-two percent of low-tau early patients showed improvement.
  • ARIA-E events were most frequent early and then declined.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.